Gossamer Bio, Inc. (GOSS)
Gossamer Bio Market Cap : 493.00M for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Madrigal Pharmaceuticals, Inc. | 9.880B |
| XOMA Royalty Corp. | 319.61M |
| Rezolute, Inc. | 314.85M |
| Axsome Therapeutics, Inc. | 9.262B |
| Crinetics Pharmaceuticals, Inc. | 4.453B |
Market Cap Related Metrics
| PS Ratio | 10.98 |
| PEG Ratio | -0.0285 |
| Price | 2.13 |
| Earnings Yield | -32.26% |
| PEGY Ratio | -0.0285 |